Ciclesonide

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand name Alvesco for asthma and Omnaris/Omniair for hay fever in the US and Canada. Phase 3 trials for the hay fever indication outside the US are ongoing. The drug was approved for adults and children 12 and over by the US Food and Drug Administration in October 2006.Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings

About Betamethasone valerate

Betamethasone is a potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties. Unlike other drugs with these effects, betamethasone does not cause water retention. It is applied as a topical cream, ointment, foam, lotion or gel to treat itching. Betamethasone sodium phosphate is sometimes prescribed as an intramuscular injection (I.M) for itching from various ailments, including allergic reactions to poison ivy and similar plants.
Betamethasone is available in a number of compound forms: betamethasone dipropionate (branded as Diprosone, Diprolene, Celestamine, Procort in Pakistan and others), sodium phosphate (branded as Bentelan in Italy[1]) and valerate (branded as Betnovate, Celestone, Fucibet, and others). In the United States and Canada, betamethasone is mixed with clotrimazole and sold as Lotrisone and Lotriderm. It is also available in combination with salicylic acid for using in psoriatic skin conditions.

About Algestone Acetophenide

Algestone Acetophenide: Algestone acetophenide is a pregnane steroid.,A progesterone that has been used in ESTRUS SYNCHRONIZATION and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also used therapeutically as a topical anti-inflammatory and is applied topically in the treatment of ACNE. 

About Amcinonide

Amcinonide  is a topical glucocorticoid used to treat itching, redness and swelling associated with several dermatologic conditions such as atopic dermatitis and allergic contact dermatitis.
Amcinonide is a topical  steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.
Amcinonide is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.

Do not use this medication if you are allergic to amcinonide.
Before using Amcinonide  opical, tell your doctor if you are allergic to any drugs, or if you have any type of skin infection.
Also tell your doctor if you have diabetes. Topical steroid medicines absorbed through the skin may increase the glucose (sugar) levels in your blood or urine.
FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether Amcinonide  opical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Product name:Amcinonide
CAS: 51022-69-6
Molecular formula: C28H35FO7
Molecular weight: 502.57
Specifications: USP29

About R-(3)-Hydroxymyristic acid

3-hydroxymyristic acid is a member of the chemical class known as Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group. Hydroxymyristic acid is a component of lipid A.
AS:28715-21-1
Molecular Formula:C14H28O3
Molecular Weight:244.37g/mol
Description:R-(3)-Hydroxymyristic acid,R-(3)-Hydroxymyristic acid,R-(3)-Hydroxymyristic acid,R-(3)-Hydroxymyristic acid.

About Emtricitabine

Emtricitabine (FTC), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection in adults and children.
Emtricitabine is also marketed in a fixed-dose combination with tenofovir (Viread) under the brand name Truvada. A fixed-dose triple combination of emtricitabine, tenofovir and efavirenz (Sustiva, marketed by Bristol-Myers Squibb) was approved by the U.S. Food and Drug Administration (FDA) on July 12, 2006 under the brand name Atripla.
Emtricitabine is an analogue of cytidine. The drug works by inhibiting reverse transcriptase, the enzyme that copies HIV RNA into new viral DNA. By interfering with this process, which is central to the replication of HIV, emtricitabine can help to lower the amount of HIV, or "viral load", in a patient's body and can indirectly increase the number of immune system cells (called T cells or CD4+ T-cells). Both of these changes are associated with healthier immune systems and decreased likelihood of serious illness.

About Budesonide

Budesonide is a glucocorticoid steroid for the treatment of asthma, COPD and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. In addition, it is used for Crohn's disease (inflammatory bowel disease).
Budesonide is nebulized for maintenance and prophylactic treatment of asthma including patients who require oral corticosteroids and those who may benefit from systemic dose reduction.

Budesonide controls the rate of protein synthesis.

Depressing the migration of polymorphonuclear leukocytes and fibroblasts.

Budesonide reverses capillary permeability and lysosomal stabilization at the cellular level to prevent or control inflammation.

Budesonide also has a potent glucocorticoid activity and weak mineralocorticoid activity.